Drug: infliximab, recombinant Quarter: 2016Q3
Total Records: 276 Number of Pages: 14
| DRUGNAME | PT | EventCount |
|---|---|---|
| INFLIXIMAB, RECOMBINANT | Clostridium difficile infection | 7 |
| INFLIXIMAB, RECOMBINANT | Emotional disorder | 7 |
| INFLIXIMAB, RECOMBINANT | Fistula | 7 |
| INFLIXIMAB, RECOMBINANT | Foetal exposure during pregnancy | 7 |
| INFLIXIMAB, RECOMBINANT | General physical health deterioration | 7 |
| INFLIXIMAB, RECOMBINANT | Intestinal stenosis | 7 |
| INFLIXIMAB, RECOMBINANT | Sepsis | 7 |
| INFLIXIMAB, RECOMBINANT | Staphylococcal infection | 7 |
| INFLIXIMAB, RECOMBINANT | Cellulitis | 6 |
| INFLIXIMAB, RECOMBINANT | Chills | 6 |
| INFLIXIMAB, RECOMBINANT | Drug effect incomplete | 6 |
| INFLIXIMAB, RECOMBINANT | Drug level below therapeutic | 6 |
| INFLIXIMAB, RECOMBINANT | Hereditary disorder | 6 |
| INFLIXIMAB, RECOMBINANT | Hypophagia | 6 |
| INFLIXIMAB, RECOMBINANT | Leukopenia | 6 |
| INFLIXIMAB, RECOMBINANT | Mental status changes | 6 |
| INFLIXIMAB, RECOMBINANT | Neoplasm malignant | 6 |
| INFLIXIMAB, RECOMBINANT | Rash morbilliform | 6 |
| INFLIXIMAB, RECOMBINANT | Surgery | 6 |
| INFLIXIMAB, RECOMBINANT | Basal cell carcinoma | 5 |
Total Records: 276 Number of Pages: 14